SIEMENS MEDICAL SOLUTIONS USA, INC

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC

Filing 1st Quarter - Report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Expenses

$590,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

SARAH ELIZABETH GIANNI New on this filing

Previously held: Staff Assistant, Office of Rep. John Larson; Scheduler and Executive Assistant, Office of Rep. John Larson

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 5

HR 2120
ROCR Value Based Program Act
S 1031
ROCR Value Based Program Act
S 1399
Health Tech Investment Act
HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HR 2381
SCREENS for Cancer Act of 2025

Lobbying activity 6

Medicare/Medicaid

H.R. 2120 / S. 1031 - Radiation Oncology Case Rate Value Based Program Act; and S. 1399 - Health Tech Investment Act. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.

Budget/Appropriations

Public Law 119 / H.R. 1968 - Full year Continuing Appropriations and Extensions Act.

Taxation/Internal Revenue Code

Public Law 115-97 (Tax Cut and Jobs Act) - issues related to expiring tax provisions.

Trade (domestic/foreign)

Issues related to availability of medical isotopes; Issues related to medical supply chains and procurement; and Issues related to international trade.

Tariff (miscellaneous tariff bills)

Issues related to tariffs and supply chain resilience.

Health Issues

H.R. 2381 -- SCREENS for Cancer Act of 2025. Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to right to repair.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.